Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H13FN4O2 |
| Molecular Weight | 312.2984 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC(NC2=NC=C(F)C(NC3=CC=CC(O)=C3)=N2)=CC=C1
InChI
InChIKey=TVKGTSHBQZEFEE-UHFFFAOYSA-N
InChI=1S/C16H13FN4O2/c17-14-9-18-16(20-11-4-2-6-13(23)8-11)21-15(14)19-10-3-1-5-12(22)7-10/h1-9,22-23H,(H2,18,19,20,21)
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Y7W5AL9KHB
Created by
admin on Sat Dec 16 11:14:23 GMT 2023 , Edited by admin on Sat Dec 16 11:14:23 GMT 2023
|
PRIMARY | |||
|
9904854
Created by
admin on Sat Dec 16 11:14:23 GMT 2023 , Edited by admin on Sat Dec 16 11:14:23 GMT 2023
|
PRIMARY | |||
|
R-921218
Created by
admin on Sat Dec 16 11:14:23 GMT 2023 , Edited by admin on Sat Dec 16 11:14:23 GMT 2023
|
PRIMARY | This is a study of the effectiveness and safety of a new nasal spray for the relief of the symptoms of seasonal allergies. The agents being compared are: R926112 (a novel anti-allergy medicine), Beconase (beclomethasone dipropionate, an established FDA approved steroid treatment), and an inactive placebo. The study hypothesis is that R926112 will be superior to placebo at the end of a week of testing and evaluation. The study does not have the power to determine how R926112 compares to Beconase. | ||
|
CHEMBL3545399
Created by
admin on Sat Dec 16 11:14:23 GMT 2023 , Edited by admin on Sat Dec 16 11:14:23 GMT 2023
|
PRIMARY | |||
|
575474-82-7
Created by
admin on Sat Dec 16 11:14:23 GMT 2023 , Edited by admin on Sat Dec 16 11:14:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
